Research progress on related factors of depression tendency in patients with multidrug resistant tuberculosis

doi:10.19982/j.issn.1000-6621.20210411

Abstract

Abstract:

Depressive tendency is one of the major problems existing in patients with Multidrug Resistant Tuberculosis (MDR-TB) which would affect patients’ treatment compliance, quality of life, mental and economic well-beings. Severe depression can lead to extreme behaviors and even suicide. This paper reviews the related factors and intervention measures of depression tendency in MDR-TB patients, and puts forward the development direction and suggestions for alleviating the psychological burden and depression tendency of patients from perspectives of individuals, families, communities, hospitals and national governments.

Key words: Tuberculosis,lung, Resistance to multiple drugs, Factor analysis

CLC Number:

R52
R473.5

ZHOU Qian-ru, WANG Ling-hua. Research progress on related factors of depression tendency in patients with multidrug resistant tuberculosis[J]. Chinese Journal of Antituberculosis, 2022, 44(2): 197-202. doi: 10.19982/j.issn.1000-6621.20210411

References 67

[1]	World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020.
[2]	Huque R, Elsey H, Fieroze F, et al. Death is a better option than being treated like this: A prevalence survey and qualitative study of depression among multi-drug resistant tuberculosis in-patients. BMC Public Health, 2020, 20(1):848. doi: 10.1186/s12889-020-08986-x. doi: 10.1186/s12889-020-08986-x pmid: 32493337
[3]	Chandra M, Rana P, Chandra K, et al. Tuberculosis-depression syndemic: A public health challenge. Indian J Tuberc, 2019, 66(1):197-202. doi: 10.1016/j.ijtb.2019.02.007. doi: 10.1016/j.ijtb.2019.02.007 URL
[4]	Walker IF, Baral SC, Wei X, et al. Multidrug-resistant tuberculosis treatment programmes insufficiently consider comorbid mental disorders. Int J Tuberc Lung Dis, 2017, 21(6):603-609. doi: 10.5588/ijtld.17.0135. doi: 10.5588/ijtld.17.0135 pmid: 28482954
[5]	Ambaw F, Mayston R, Hanlon C, et al. Untreated depression and tuberculosis treatment outcomes, quality of life and disability, Ethiopia. Bull World Health Organ, 2018, 96(4):243-255. doi: 10.2471/BLT.17.192658. doi: 10.2471/BLT.17.192658 URL
[6]	中国防痨协会. 耐药结核病化学治疗指南(2019年简版). 中国防痨杂志, 2019, 41(10):1025-1073. doi: 10.3969/j.issn.1000-6621.2019.10.001. doi: 10.3969/j.issn.1000-6621.2019.10.001
[7]	Malhi GS, Mann JJ. Depression. Lancet, 2018, 392(10161):2299-2312. doi: 10.1016/S0140-6736(18)31948-2. doi: S0140-6736(18)31948-2 pmid: 30396512
[8]	American Psychiatric Association. Diagnostic and statistical manual of mental disorders,f-ifth edition(DSM-5). Arlington,VA:American Psychiatric Association, 2013.
[9]	中华医学会精神病学分会. 中国精神障碍分类与诊断标准第三版(精神障碍分类). 中华精神科杂志, 2001, 34(3):184-188. doi: 10.3760/j:issn:1006-7884.2001.03.028. doi: 10.3760/j:issn:1006-7884.2001.03.028
[10]	Mohammedhussein M, Alenko A, Tessema W, et al. Prevalence and associated factors of depression and anxiety among patients with pulmonary tuberculosis attending treatment at public health facilities in Southwest Ethiopia. Neuropsychiatr Dis Treat, 2020, 16:1095-1104. doi: 10.2147/NDT.S249431. doi: 10.2147/NDT.S249431 URL
[11]	Duko B, Bedaso A, Ayano G. The prevalence of depression among patients with tuberculosis: A systematic review and meta-analysis. Ann Gen Psychiatry, 2020, 19:30. doi: 10.1186/s12991-020-00281-8. doi: 10.1186/s12991-020-00281-8 URL
[12]	Walker IF, Kanal S, Baral SC, et al. Depression and anxiety in patients with multidrug-resistant tuberculosis in Nepal: An observational study. Public Health Action, 2019, 9(1):42-48. doi: 10.5588/pha.18.0047. doi: 10.5588/pha.18.0047 pmid: 30963041
[13]	Chen B, Peng Y, Zhou L, et al. Social support received by multidrug-resistant tuberculosis patients and related factors: A cross-sectional study in Zhejiang Province, People’s Republic of China. Patient Prefer Adherence, 2016, 10:1063-1070. doi: 10.2147/PPA.S105655. doi: 10.2147/PPA.S105655
[14]	Stoichita A, Dumitrescu A, Ciobanu A, et al. Depression and anxiety symptoms among people with rifampicin-resistant tuberculosis receiving in-patient care in the National Pulmonology Reference Institute in Romania. Monaldi Arch Chest Dis, 2021, 91(1). doi: 10.4081/monaldi.2021.1704. doi: 10.4081/monaldi.2021.1704
[15]	Hayes-Larson E, Hirsch-Moverman Y, Saito S, et al. Depressive symptoms and hazardous/harmful alcohol use are prevalent and correlate with stigma among TB-HIV patients in lesotho. Int J Tuberc Lung Dis, 2017, 21(11):34-41. doi: 10.5588/ijtld.17.0062. doi: 10.5588/ijtld.17.0062 pmid: 29025483
[16]	Tomita A, Ramlall S, Naidu T, et al. Major depression and household food insecurity among individuals with multidrug-resistant tuberculosis (MDR-TB) in south africa. Soc Psychiatry Psychiatr Epidemiol, 2019, 54(3):387-393. doi: 10.1007/s00127-019-01669-y. doi: 10.1007/s00127-019-01669-y URL
[17]	陈曦, 赵瑶, 许琰, 等. 北京市肺结核患者抑郁和焦虑现况及其影响因素. 中华医学杂志, 2016, 96(34):2749-2753. doi: 10.3760/cma.j.issn.0376-2491.2016.34.013. doi: 10.3760/cma.j.issn.0376-2491.2016.34.013
[18]	Dasa TT, Roba AA, Weldegebreal F, et al. Prevalence and associated factors of depression among tuberculosis patients in Eastern Ethiopia. Bmc Psychiatry, 2019, 19(1):82. doi: 10.1186/s12888-019-2042-6. doi: 10.1186/s12888-019-2042-6 URL
[19]	Jang JG, Chung JH. Diagnosis and treatment of multidrug-resistant tuberculosis. Yeungnam Univ J Med, 2020, 37(4):277-285. doi: 10.12701/yujm.2020.00626. doi: 10.12701/yujm.2020.00626 URL
[20]	张艳霞, 卢经伟. 耐多药肺结核患者心理健康状况及其影响因素分析. 临床合理用药杂志, 2019, 12(11):125-126. doi: 10.15887/j.cnki.13-1389/r. doi: 10.15887/j.cnki.13-1389/r
[21]	Kizito E, Musaazi J, Mutesasira K, et al. Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda-a case-control study. BMC Infect Dis, 2021, 21(1):292. doi: 10.1186/s12879-021-05967-2. doi: 10.1186/s12879-021-05967-2 pmid: 33752637
[22]	Sineke T, Evans D, Schnippel K, et al. The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa. Health Qual Life Outcomes, 2019, 17(1):94. doi: 10.1186/s12955-019-1155-4. doi: 10.1186/s12955-019-1155-4 URL
[23]	Walker IF, Khan AM, Khan AM, et al. Depression among multidrug-resistant tuberculosis patients in Punjab, Pakistan: A large cross-sectional study. Int J Tuberc Lung Dis, 2018, 22(7):773-778. doi: 10.5588/ijtld.17.0788. doi: 10.5588/ijtld.17.0788 pmid: 29914603
[24]	Jaber AAS, Ibrahim B. Health-related quality of life of patients with multidrug-resistant tuberculosis in yemen: Prospective study. Health Qual Life Outcomes, 2019, 17(1):142. doi: 10.1186/s12955-019-1211-0. doi: 10.1186/s12955-019-1211-0 URL
[25]	符婷, 黄丽菊, 杨进军, 等. 308例耐多药肺结核患者心理健康状况及其影响因素分析. 中国防痨杂志, 2020, 42(4):366-371. doi: 10.3969/j.issn.1000-6621.2020.04.012. doi: 10.3969/j.issn.1000-6621.2020.04.012
[26]	Anujuo K, Stronks K, Snijder MB, et al. Association between depressed mood and sleep duration among various ethnic groups-the helius study. Int J Environ Res Public Health, 2021, 18(13):7134. doi: 10.3390/ijerph18137134. doi: 10.3390/ijerph18137134 URL
[27]	Tenzin C, Chansatitporn N, Dendup T, et al. Factors associa-ted with multidrug-resistant tuberculosis (MDR-TB) in Bhutan: A nationwide case-control study. PLoS One, 2020, 15(7):e0236250. doi: 10.1371/journal.pone.0236250. doi: 10.1371/journal.pone.0236250 URL
[28]	Heo IR, Kim JY, Go SI, et al. Chronic cough is associated with depressive mood in women regardless of smoking status and lung function. Clin Respir J, 2021, 15(7):753-760. doi: 10.1111/crj.13357. doi: 10.1111/crj.13357 pmid: 33715313
[29]	Sohn KH, Song WJ, Kim SH, et al. Chronic cough, not asthma, is associated with depression in the elderly: A community-based population analysis in South Korea. Korean J Intern Med, 2019, 34(6):1363-1371. doi: 10.3904/kjim.2018.187. doi: 10.3904/kjim.2018.187 URL
[30]	Fukunaga R, Glaziou P, Harris JB, et al. Epidemiology of tuberculosis and progress toward meeting global targets-worldwide, 2019. MMWR Morb Mortal Wkly Rep, 2021, 70(12):427-4430. doi: 10.15585/mmwr.mm7012a4. doi: 10.15585/mmwr.mm7012a4 URL
[31]	Chem ED, Van Hout MC, Hope V. Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: A systematic review and meta-analysis. BMC Infect Dis, 2019, 19(1):723. doi: 10.1186/s12879-019-4317-4. doi: 10.1186/s12879-019-4317-4 URL
[32]	Yohannes K, Mokona H, Abebe L, et al. Prevalence of depressive symptoms and associated factors among patients with tuberculosis attending public health institutions in Gede’o zone, South Ethiopia. BMC Public Health, 2020, 20(1):1702. doi: 10.1186/s12889-020-09794-z. doi: 10.1186/s12889-020-09794-z URL
[33]	Theingi P, Kamiya Y, Myat Moe M, et al. Depression and its associated factors among people with multidrug-resistant tuberculosis in Myanmar. Trop Med Int Health, 2021, 26(9):1117-1126. doi: 10.1111/tmi.13637. doi: 10.1111/tmi.13637 pmid: 34110669
[34]	Duko B, Gebeyehu A, Ayano G. Prevalence and correlates of depression and anxiety among patients with tuberculosis at Wolaitasodo University Hospital and Sodo Health Center, Wolaitasodo, South Ethiopia, Cross sectional study. Bmc Psychiatry, 2015, 15:214. doi: 10.1186/s12888-015-0598-3. doi: 10.1186/s12888-015-0598-3 URL
[35]	Reviono R, Harsini H, Aphridasari J, et al. Influence social and healthcare support on psychiatric adverse events in MDR-TB patient. J Infect Dev Ctries, 2018, 12(7):592-596. doi: 10.3855/jidc.10352. doi: 10.3855/jidc.10352 URL
[36]	Gong Y, Yan S, Qiu L, et al. Prevalence of depressive symptoms and related risk factors among patients with tuberculosis in china: A multistage cross-sectional study. Am J Trop Med Hyg, 2018, 98(6):1624-1628. doi: 10.4269/ajtmh.17-0840. doi: 10.4269/ajtmh.17-0840 URL
[37]	Sagili KD, Satyanarayana S, Chadha SS. Is knowledge regarding tuberculosis associated with stigmatising and discriminating attitudes of general population towards tuberculosis patients? Findings from a community based survey in 30 districts of India. PLoS One, 2016, 11(2):e0147274. doi: 10.1371/journal.pone.0147274. doi: 10.1371/journal.pone.0147274 URL
[38]	Gupta A, Swindells S, Kim S, et al. Feasibility of identifying household contacts of rifampin-and multidrug-resistant tuberculosis cases at high risk of progression to tuberculosis disease. Clin Infect Dis, 2020, 70(3):425-435. doi: 10.1093/cid/ciz235. doi: 10.1093/cid/ciz235 URL
[39]	Baral SC, Aryal Y, Bhattrai R, et al. The importance of providing counselling and financial support to patients receiving treatment for multi-drug resistant TB: Mixed method qualitative and pilot intervention studies. BMC Public Health, 2014, 14:46. doi: 10.1186/1471-2458-14-46. doi: 10.1186/1471-2458-14-46 URL
[40]	Dong X, Zhao L, Sun T, et al. Prevalence of depressive symptoms and associated factors among internal migrants with tuberculosis: A cross-sectional study in China. Am J Trop Med Hyg, 2020, 102(1):31-35. doi: 10.4269/ajtmh.19-0542. doi: 10.4269/ajtmh.19-0542 URL
[41]	Yin X, Yan S, Tong Y, et al. Status of tuberculosis-related stigma and associated factors: A cross-sectional study in central China. Trop Med Int Health, 2018, 23(2):199-205. doi: 10.1111/tmi.13017. doi: 10.1111/tmi.13017 URL
[42]	Galhenage JS, Rupasinghe JP, Abeywardena GS, et al. Psychological morbidity and illness perception among patients receiving treatment for tuberculosis in a tertiary care centre in sri lanka. Ceylon Med J, 2016, 61(1):37-40. doi: 10.4038/cmj.v61i1.8261. doi: 10.4038/cmj.v61i1.8261 URL
[43]	Burtscher D, Van den Bergh R, Toktosunov U, et al. “My favourite day is sunday”: Community perceptions of (drug-resistant) tuberculosis and ambulatory tuberculosis care in Kara Suu District, Osh Province, Kyrgyzstan. PLoS One, 2016, 11(3):e0152283. doi: 10.1371/journal.pone.0152283. doi: 10.1371/journal.pone.0152283 URL
[44]	Bieh KL, Weigel R, Smith H. Hospitalized care for mdr-tb in Port Harcourt, Nigeria: A qualitative study. BMC Infect Dis, 2017, 17(1):50. doi: 10.1186/s12879-016-2114-x. doi: 10.1186/s12879-016-2114-x URL
[45]	Fuady A, Houweling TAJ, Mansyur M, et al. Effect of financial support on reducing the incidence of catastrophic costs among tuberculosis-affected households in Indonesia: Eight simulated scenarios. Infect Dis Poverty, 2019, 8(1):10. doi: 10.1186/s40249-019-0519-7. doi: 10.1186/s40249-019-0519-7 URL
[46]	Wen S, Yin J, Sun Q. Impacts of social support on the treatment outcomes of drug-resistant tuberculosis: A systematic review and meta-analysis. BMJ Open, 2020, 10(10):e036985. doi: 10.1136/bmjopen-2020-036985. doi: 10.1136/bmjopen-2020-036985 URL
[47]	Khanal S, Elsey H, King R, et al. Development of a patient-centred, psychosocial support intervention for multi-drug-resistant tuberculosis (MDR-TB) care in nepal. PLoS One, 2017, 12(1):e0167559. doi: 10.1371/journal.pone.0167559. doi: 10.1371/journal.pone.0167559 URL
[48]	卞崔冬, 何筱衍, 钱洁, 等. 患者健康问卷抑郁症状群量表在综合性医院中的应用研究. 同济大学学报(医学版), 2009, 30(5):136-140.
[49]	Ambaw F, Mayston R, Hanlon C, et al. Incidence of depression in people with newly diagnosed tuberculosis in Ethiopia: A cohort study. Glob Ment Health (Camb), 2020, 7:e1. doi: 10.1017/gmh.2019.27. doi: 10.1017/gmh.2019.27
[50]	Molla A, Mekuriaw B, Kerebih H. Depression and associated factors among patients with tuberculosis in ethiopia: A cross-sectional study. Neuropsychiatr Dis Treat, 2019, 15:1887-1893. doi: 10.2147/NDT.S208361. doi: 10.2147/NDT.S208361 URL
[51]	Madan JJ, Rosu L, Tefera MG, et al. Economic evaluation of short treatment for multidrug-resistant tuberculosis, ethiopia and South Africa: The stream trial. Bull World Health Organ, 2020, 98(5):306-314. doi: 10.2471/BLT.19.243584. doi: 10.2471/BLT.19.243584 URL
[52]	Horter S, Achar J, Gray N, et al. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan. PLoS One, 2020, 15(11):e0242359. doi: 10.1371/journal.pone.0242359. doi: 10.1371/journal.pone.0242359 URL
[53]	王艳玲. 耐多药肺结核治疗不良反应发生情况的分析. 世界最新医学信息文摘, 2019, 19(54):75-77. doi: 10.19613/j.cnki.1671-3141.2019.54.043. doi: 10.19613/j.cnki.1671-3141.2019.54.043
[54]	高扬, 邵雨辰, 苏明珠, 等. 癌症患者的多学科团队协作诊疗模式研究进展. 中国医院管理, 2019, 39(3):34-37.
[55]	胡雪丹, 吴爱莲, 黄茶英, 等. 多学科诊疗护理模式在耐多药肺结核病中的疗效观察. 临床医药实践, 2021, 30(2):138-140.
[56]	Günther G, van Leth F, Alexandru S, et al. Clinical management of multidrug-resistant tuberculosis in 16 european countries. Am J Respir Crit Care Med, 2018, 198(3):379-386. doi: 10.1164/rccm.201710-2141OC. doi: 10.1164/rccm.201710-2141OC URL
[57]	Xu M, Markström U, Lyu J, et al. Survey on tuberculosis patients in rural areas in china: Tracing the role of stigma in psychological distress. Int J Environ Res Public Health, 2017, 14(10):1171. doi: 10.3390/ijerph14101171. doi: 10.3390/ijerph14101171 URL
[58]	Chen X, Du L, Wu R, et al. Tuberculosis-related stigma and its determinants in Dalian, Northeast China: A cross-sectional study. BMC Public Health, 2021, 21(1):6. doi: 10.1186/s12889-020-10055-2. doi: 10.1186/s12889-020-10055-2 pmid: 33397334
[59]	Walker IF, Khanal S, Hicks JP, et al. Implementation of a psychosocial support package for people receiving treatment for multidrug-resistant tuberculosis in Nepal: A feasibility and acceptability study. PLoS One, 2018, 13(7):e0201163. doi: 10.1371/journal.pone.0201163. doi: 10.1371/journal.pone.0201163 URL
[60]	Yin J, Wang X, Zhou L, et al. The relationship between social support, treatment interruption and treatment outcome in patients with multidrug-resistant tuberculosis in China: A mixed-methods study. Trop Med Int Health, 2018, 23(6):668-677. doi: 10.1111/tmi.13066. doi: 10.1111/tmi.13066 URL
[61]	徐辉, 刘敏. 正念减压疗法对减轻耐多药肺结核病患者精神压力的影响. 齐鲁护理杂志, 2017, 23(15):124-126. doi: 10.3969/j.issn.1006-7256.2017.15.055. doi: 10.3969/j.issn.1006-7256.2017.15.055
[62]	王坚杰, 易凤莲, 陈聪, 等. 团体心理辅导对耐多药结核病患者的抑郁症状干预效果. 公共卫生与预防医学, 2017, 28(1):50-52.
[63]	Gils T, Laxmeshwar C, Duka M, et al. Preparedness of outpatient health facilities for ambulatory treatment with all-oral short DR-TB treatment regimens in Zhytomyr, Ukraine: A cross-sectional study. BMC Health Serv Res, 2020, 20(1):890. doi: 10.1186/s12913-020-05735-z. doi: 10.1186/s12913-020-05735-z URL
[64]	覃红娟, 谭守勇, 邝浩斌, 等. 耐多药肺结核患者住院与门诊治疗对疗效的影响. 实用医学杂志, 2013, 29(23):3811-3814. doi: 10.3969/j.issn.1006-5725.2013.23.009. doi: 10.3969/j.issn.1006-5725.2013.23.009
[65]	张立强, 程斌, 宋大平, 等. 我国耐多药肺结核病纳入新型农村合作医疗补偿政策现状与思考. 中国初级卫生保健, 2013, 27(2):14-16. doi: 10.3969/j.issn.1001-568x.2013.02.0005. doi: 10.3969/j.issn.1001-568x.2013.02.0005
[66]	王芸, 禄晓龙. 结核病高疫情省份城乡居民耐多药结核病基本医保政策比较. 现代医药卫生, 2020, 36(20):3226-3229,3233. doi: 10.3969/j.issn.1009-5519.2020.20.013. doi: 10.3969/j.issn.1009-5519.2020.20.013
[67]	Long Q, Jiang WX, Zhang H, et al. Multi-source financing for tuberculosis treatment in China: Key issues and challenges. Infect Dis Poverty, 2021, 10(1):17. doi: 10.1186/s40249-021-00809-4. doi: 10.1186/s40249-021-00809-4 URL